Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations.

Autor:	Spring LK; Dermatology Department, Naval Hospital Camp Lejeune, Camp Lejeune, North Carolina., Krakowski AC; DermOne, LLC, West Conshohocken, Pennsylvania., Alam M; Department of Dermatology, Northwestern University, Chicago, Illinois., Bhatia A; DuPage Medical Group, Department of Dermatology, Northwestern University, Chicago, Illinois., Brauer J; Laser and Skin Surgery Center of New York, New York.; Department of Dermatology, New York University School of Medicine, New York., Cohen J; AboutSkin Dermatology, Lone Tree, Colorado.; DermSurgery, Lone Tree, Colorado., Del Rosso JQ; Dermatology Department, Touro University Nevada College of Health and Human Services, Henderson., Diaz L; Dell Children's Medical Center, University of Texas Austin Dell Medical School, Austin., Dover J; SkinCare Physicians, Chestnut Hill, Massachusetts., Eichenfield LF; Department of Dermatology, University of California-San Diego.; Rady Children's Hospital, San Diego, California., Gurtner GC; Stanford University, Stanford, California., Hanke CW; Laser and Skin Surgery Center of Indiana, Carmel., Jahnke MN; Department of Dermatology, Henry Ford Health System, Detroit, Michigan.; Division of Pediatric Dermatology, Children's Hospital of Michigan, Detroit, Michigan., Kelly KM; University of California-Irvine., Khetarpal S; SkinCare Physicians, Chestnut Hill, Massachusetts., Kinney MA; Wilmington Health, PLLC, Wilmington, North Carolina., Levy ML; Dell Children's Medical Center, University of Texas Austin Dell Medical School, Austin., Leyden J; University of Pennsylvania, Philadelphia., Longaker MT; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California., Munavalli GS; Department of Dermatology, School of Medicine, Wake Forest University, Charlotte, North Carolina.; Dermatology, Laser, and Vein Specialists of the Carolinas, PLLC, Charlotte, North Carolina., Ozog DM; Department of Dermatology, Henry Ford Hospital, Detroit, Michigan., Prather H; Westlake Dermatology, Austin, Texas., Shumaker PR; Naval Medical Center San Diego, San Diego, California., Tanzi E; Dermatology Department, George Washington University School of Medicine, Washington, DC., Torres A; Loma Linda University Medical Center, Loma Linda, California., Velez MW; SkinCare Physicians, Chestnut Hill, Massachusetts., Waldman AB; Brigham and Women's Hospital, Boston, Massachusetts., Yan AC; Section of Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics and Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Zaenglein AL; Pennsylvania State University, Hershey.
Jazyk:	angličtina
Zdroj:	JAMA dermatology [JAMA Dermatol] 2017 Aug 01; Vol. 153 (8), pp. 802-809.
DOI:	10.1001/jamadermatol.2017.2077
Abstrakt:	Importance: The notion that systemic isotretinoin taken within 6 to 12 months of cutaneous surgery contributes to abnormal scarring or delayed wound healing is widely taught and practiced; however, it is based on 3 small case series from the mid-1980s. Objective: To evaluate the body of literature to provide evidence-based recommendations regarding the safety of procedural interventions performed either concurrently with, or immediately following the cessation of systemic isotretinoin therapy. Evidence Review: A panel of national experts in pediatric dermatology, procedural/cosmetic dermatology, plastic surgery, scars, wound healing, acne, and isotretinoin was convened. A systematic PubMed review of English-language articles published from 1982 to 2017 was performed using the following search terms: isotretinoin, 13-cis-retinoic acid, Accutane, retinoids, acitretin, surgery, surgical, laser, ablative laser, nonablative laser, laser hair removal, chemical peel, dermabrasion, wound healing, safety, scarring, hypertrophic scar, and keloid. Evidence was graded, and expert consensus was obtained. Findings: Thirty-two relevant publications reported 1485 procedures. There was insufficient evidence to support delaying manual dermabrasion, superficial chemical peels, cutaneous surgery, laser hair removal, and fractional ablative and nonablative laser procedures for patients currently receiving or having recently completed isotretinoin therapy. Based on the available literature, mechanical dermabrasion and fully ablative laser are not recommended in the setting of systemic isotretinoin treatment. Conclusions and Relevance: Physicians and patients may have an evidence-based discussion regarding the known risk of cutaneous surgical procedures in the setting of systemic isotretinoin therapy. For some patients and some conditions, an informed decision may lead to earlier and potentially more effective interventions.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu